RNAC- Cartesian Therapeutics, Inc.

Name: Cartesian Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

RNAC sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Springer Timothy A	8.65M	-	-
10%	Kalayoglu Murat	5.31M	-	-
CEO	Brunn Carsten	323.5K	$2.21M	-
CFO	Davis Blaine	121.2K	$826.7K	-
Other	English Emily	94.2K	-	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 6, 2026	Davis Blaine75	Chief Financial Officer	Sell	10,591	$6.82	$72,227.44	-8.0%	-11.4%	-
Jan 6, 2026	Miljkovic Milos73	Chief Medical Officer	Sell	3,573	$6.82	$24,366.79	-5.7%	-11.4%	-
Jan 6, 2026	Brunn Carsten86	President And CEO	Sell	23,766	$6.82	$162,076.99	-6.8%	-11.4%	-
Dec 4, 2025	Barabe Timothy C49	Director	Buy	30,000	$6.86	$205,797.00	+123.1%	+14.2%	-
Apr 11, 2025	Springer Timothy A49	Director, 10% Owner	Buy	149,075	$10.21	$1,522,517.04	+29.4%	+26.9%	-44.0%
Mar 20, 2025	Springer Timothy A49	Director, 10% Owner	Buy	89,863	$15.26	$1,371,154.37	+1.1%	-37.2%	-59.1%
Jan 14, 2025	Springer Timothy A49	Director, 10% Owner	Buy	20,967	$17.47	$366,353.71	+0.2%	-27.9%	-57.6%
Jan 6, 2025	Davis Blaine75	Chief Financial Officer	Sell	7,989	$16.78	$134,035.55	-7.8%	-42.7%	-60.1%
Jan 6, 2025	Brunn Carsten86	President And CEO	Sell	17,271	$16.78	$289,764.43	-7.8%	-42.7%	-60.1%
Jan 6, 2025	English Emily	Chief Operations Officer	Sell	1,797	$16.78	$30,149.19	-4.3%	-42.7%	-60.1%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC